Delivery Order SPE2DB22D3301-SPE2DB23FZ2LP
Award Date 8/2/23
Potential Completion Date 8/3/23
Potential Value $306
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,954.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/20 ml vials of ropivacaine hydrochloride injection 1%. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is for a single day of delivery on July 18, 2023 to fulfill DLA requirements, with no subcontractors involved. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this...
- The Defense Logistics Agency awarded a $381,690 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ropivacaine 0.2% 20 mg/10 ml 10ml. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from June 21, 2023 through June 22, 2023. No additional context was provided regarding the Defense Logistics Agency's programs or any associated contracts. The award information indicates a delivery order for pharmaceutical products but...
- The Defense Logistics Agency awarded a $1,355.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% 20 mg/10 mL in 10 mL vials. The contract, issued on September 3, 2025, with completion targeted for September 4, 2025, represents a direct procurement of pharmaceutical products to support military and federal healthcare operations. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $12,669.85 firm fixed price delivery order by the Defense Logistics Agency to supply 4561610964 Ropivacaine 0.2% 400 mg/200 ml solution in 200 ml containers. Performance will take place in Conshohocken, Pennsylvania over one day from July 26 to July 27, 2023. The delivery order was issued under an existing DLA pharmaceuticals contract vehicle to fulfill agency medical supply needs. No...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,410.92 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml units) with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a $5,112.84 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ropivacaine 0.2% 200 mg/100 mL in 100 mL quantities. This delivery order represents a firm fixed price contract with no set-aside designation, utilizing open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. The delivery order is issued...
- The Defense Logistics Agency awarded a $7,619 delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The single delivery order is for 200 ml of the specified product and will be fulfilled by August 8, 2023 out of Amerisourcebergen's facility in Conshohocken, Pennsylvania. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor for the DOD and...
- <p>The Defense Logistics Agency awarded a $244,950 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ropivacaine 0.5% 150 mg/30 ml vials. The place of performance is Conshohocken, Pennsylvania. The delivery order runs from June 23, 2023 through June 26, 2023 to supply the anesthetic drug to support DLA procurement programs. As the prime contractor, Amerisourcebergen will deliver the Ropivacaine vials without involvement of major subcontractors under the contract.</p>
- The Defense Logistics Agency Troop Support Medical awarded a $451.50 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 150 mg/30 ml vials of ropivacaine hydrochloride injection 0.5%. As the prime contractor, Amerisourcebergen Drug will deliver the local anesthetic to its place of performance in Conshohocken, Pennsylvania within the one day period of August 29-30, 2023. The delivery order was placed against an existing DLA medical supply vehicle and no...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $7,323 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561890410, which is Ropivacaine 0.2% 400 MG/200 ML in 200ML containers. Performance will take place in Conshohocken, Pennsylvania over one day in August 2023 to deliver the requested pharmaceutical product. No set aside designation or subcontractors were indicated. This order supports DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ2LPDelivery Order
The Defense Logistics Agency awarded a $306 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561682009 Ropivacaine 0.5% 100 MG/20 ML 20ML. The place of performance is Conshohocken, Pennsylvania. The order is for a single day's supply of the specified pharmaceutical to support DLA's medical materiel procurement programs. As the prime, Amerisourcebergen Drug Corporation will fulfill the order without involvement of major subcontractors. The award draws from DLA's pharmaceutical distribution contracts to cost-effectively meet short-term medical readiness requirements.
Generated 12/24/23, 6:00 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $306 | 8/2/23 |